First Workflow Built on Soficca

Structured treatment. Longitudinal care.

Pen starts with hair loss treatment in Latin America, but the real value is not just helping users begin. It is building a care flow that carries patient context forward across every review.

Pen is the first real product built on Soficca — a monetizable entry point that validates governed intake, clinical decision logic, and follow-up over time with real users.

decision_report · v0.3 ● LIVE
Product Pen — Men's Health Clinic Live
Market Mexico · Latin America Phase 1
Condition Hair loss — androgenic alopecia
Powered by Soficca Active
Safety Gate Contraindication screening Clear
Routing Deterministic · Auditable
// Sample Decision Output
status: DECIDED
path: PATH_MEDS_OK
flags: none
safety: CLEAR · no triggers
policy_version: v0.3
recommendation: proceed to clinician review
Structured intake Safety policy enforcement Deterministic routing Clinician-reviewed Longitudinal decision context Versionable decisions Auditable trace 100% online Structured intake Safety policy enforcement Deterministic routing Clinician-reviewed Longitudinal decision context Versionable decisions Auditable trace 100% online

Access is only the beginning. Care is still fragmented.

The gap is not only access to treatment. It is what happens after treatment begins.

Medication access may be fragmented, but the bigger failure is continuity: follow-up, progress tracking, and next-step care are often manual, inconsistent, or missing.

Online access is starting to exist, but continuity still does not. That leaves room for a more structured treatment workflow.

Large underserved category
Hair loss is common, but structured continuity in treatment is still limited across LatAm.
No structured follow-up layer
Most current options help users begin treatment, but not carry case history forward.

50+ real intakes reshaped the product

What early cases made clear

The real gap is not only access to treatment, but what happens after treatment begins.

Across early cases, we kept seeing the same pattern: fragmented access, weak medication control, and follow-up that is often manual or missing.

That is what pushed Pen beyond one-time evaluation and toward a structured longitudinal workflow.

01
Decision-ready intake
Symptoms, history, goals, and treatment context are captured in a governed, decision-ready format.
02
Follow-up built in
Pen does not stop after evaluation. It is designed around checkpoints that make follow-up part of the product.
03
Better continuity
Each follow-up adds clinical context, making future reviews and care decisions more informed.

From intake to treatment to follow-up

Pen is a real treatment path: governed intake, decision logic, treatment selection, and follow-up checkpoints over time.

01 //
Guided intake
Users complete a guided intake covering symptoms, history, goals, and relevant treatment context.
02 //
Decision layer
Soficca evaluates the case, applies eligibility and safety logic, and produces a governed decision output.
03 //
Treatment path
Users receive a treatment path designed for continuity, not just initial conversion.
04 //
Follow-up over time
Baseline, week 6, month 3, and month 6 checkpoints build cumulative case history over time.
Decision Report DECIDED
age29
concernhair_loss
contraindicationsnone_reported
goalslow_progression · improve_density
statusCLEAR
actionNONE
triggersnone
statusDECIDED
pathPATH_MEDS_OK
flagsnone
recommendationproceed → clinician_review
rules_evaluatedeligibility · contraindication · safety
evidence_sourceuser_intake
policy_versionv0.3

See the workflow in motion

A real checkpoint inside Pen's treatment flow. This is where follow-up becomes visible over time.

Pen — Month 3 checkpoint inside the longitudinal treatment flow

The wedge is treatment. The value compounds through continuity.

Most digital treatment options help users start. Pen is being built to make each next review more informed by preserving case history and review context over time.

Persistent case history
Every intake and follow-up produces a decision record that persists across reviews.
Follow-up across checkpoints
Baseline, week 6, month 3, month 6 — continuity is part of the product.
Reusable safety logic
Eligibility, contraindication, and routing logic that applies consistently across cases.
Built on Soficca
The decision layer underneath Pen is designed to be reusable across additional care environments.

Monetized through Pen. Validated through real use.

Pen is the first monetized product built on Soficca. The initial pricing is designed to be accessible in Latin America while covering intake, treatment, and follow-up.

$24/month
Starting price · Latin America
Clinical evaluation
Decision-ready intake and eligibility assessment.
Treatment path
Continuity-designed path from evaluation to care.
Follow-up over time
Scheduled checkpoints from baseline through month 6.
Treatment through licensed partner labs
As applicable, prescribed through clinician review and partner pharmacy fulfillment.

Built fast. Grounded in real use.

From first build to real intake, Pen has been developed as a functioning product rather than a deck concept — combining real intake, decision logic, and follow-up design.

50+ real intakes completed
Real users, real decision outputs, real data — not simulations.
First workflow live
Pen is operational with governed intake, decision logic, and clinician review.
Built from November 2025 to April 2026
Product, infrastructure, and care flow designed and deployed in under six months.
Clinical audit & regulatory advisor onboarded
Advisory support for documentation discipline, audit-readiness, and regulatory alignment.

Clinical audit & regulatory advisor

Pen's clinical audit and regulatory alignment is supported by an external advisor with direct healthcare operations experience.

// Carlos Pérez
Role: Clinical Audit & Regulatory Advisor

10+ years in healthcare operations and regulatory processes in Colombia. Currently at Nueva EPS. Advises Soficca on documentation discipline, audit-readiness, and regulatory alignment.

Pen is the first workflow. Soficca is the layer underneath.

Pen began as a treatment workflow, but building it made the underlying need clear: structured routing, follow-up logic, and continuity could not remain one-off product decisions.

Soficca is the reusable decision layer that emerged underneath that workflow.

// Soficca · Clinical Decision Infrastructure

Pen validates the decision layer. Soficca is the infrastructure that scales it — the same governed intake, safety logic, and care context applied across additional conditions and environments.

See Soficca →